HUP9901935A3 - Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) - Google Patents

Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)

Info

Publication number: HUP9901935A3
Authority: HU; Hungary
Prior art keywords: gags; glycosaminoglycans; dosages; targeting; medicine
Prior art date: 1995-12-01

Application number

HU9901935A

Other languages

Hungarian (hu)

Original Assignee

Jagotec Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-01

Filing date

1996-11-29

Publication date

2001-04-28

1995-12-01 Priority claimed from CA002164260A external-priority patent/CA2164260C/en

1996-03-29 Priority claimed from CA 2173037 external-priority patent/CA2173037A1/en

1996-11-29 Application filed by Jagotec Ag filed Critical Jagotec Ag

1999-11-29 Publication of HUP9901935A2 publication Critical patent/HUP9901935A2/en

2001-04-28 Publication of HUP9901935A3 publication Critical patent/HUP9901935A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

HU9901935A 1995-12-01 1996-11-29 Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) HUP9901935A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002164260A CA2164260C (en)	1995-12-01	1995-12-01	Targeting of dosages of medicines and therapeutic agents
CA 2173037 CA2173037A1 (en)	1996-03-29	1996-03-29	Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags)

Publications (2)

Publication Number	Publication Date
HUP9901935A2 HUP9901935A2 (en)	1999-11-29
HUP9901935A3 true HUP9901935A3 (en)	2001-04-28

Family

ID=25678243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9901935A HUP9901935A3 (en)	1995-12-01	1996-11-29	Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)

Country Status (11)

Country	Link
EP (1)	EP0869798A1 (en)
JP (1)	JP2000513707A (en)
KR (1)	KR19990071628A (en)
AU (1)	AU727001B2 (en)
BR (1)	BR9611671A (en)
HU (1)	HUP9901935A3 (en)
IL (1)	IL124647A0 (en)
MX (1)	MX9804343A (en)
NO (1)	NO982441D0 (en)
PL (1)	PL326970A1 (en)
WO (1)	WO1997020564A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITPD940054A1 (en) *	1994-03-23	1995-09-23	Fidia Advanced Biopolymers Srl	SULPHATED POLYSACCHARIDES
JP4790911B2 (en)	1999-01-13	2011-10-12	アルケミアオンコロジーピーティワイリミテッド	Compositions and methods for enhancing the efficacy of drugs
AUPQ879500A0 (en)	2000-07-14	2000-08-10	Meditech Research Limited	Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en)	2000-07-14	2015-06-30	Alchemia Oncology Pty Limited	Hyaluronan as a chemo-sensitizer in the treatment of cancer
CN101287474B (en)	2005-07-27	2014-08-20	阿尔卡米亚肿瘤学股份有限公司	Therapeutic protocols using hyaluronan
JP5627181B2 (en)	2005-09-07	2014-11-19	アルケミアオンコロジーピーティーワイリミテッド	Therapeutic compositions comprising hyaluronan and therapeutic antibodies and methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
AUPM714794A0 (en) *	1994-07-29	1994-08-18	International Fluid Separation Pty Limited	Separation apparatus and method
EP0778776A1 (en) *	1994-08-30	1997-06-18	Hyal Pharmaceutical Corporation	Hyaluronic acid and derivatives for modulation of cellular activity

1996
- 1996-11-29 PL PL96326970A patent/PL326970A1/en unknown
- 1996-11-29 IL IL12474796A patent/IL124647A0/en not_active IP Right Cessation
- 1996-11-29 AU AU76878/96A patent/AU727001B2/en not_active Ceased
- 1996-11-29 JP JP09520818A patent/JP2000513707A/en not_active Ceased
- 1996-11-29 BR BR9611671-4A patent/BR9611671A/en not_active Application Discontinuation
- 1996-11-29 KR KR1019980703904A patent/KR19990071628A/en not_active Application Discontinuation
- 1996-11-29 EP EP96939774A patent/EP0869798A1/en not_active Ceased
- 1996-11-29 WO PCT/CA1996/000793 patent/WO1997020564A1/en not_active Application Discontinuation
- 1996-11-29 HU HU9901935A patent/HUP9901935A3/en unknown
1998
- 1998-05-28 NO NO982441A patent/NO982441D0/en unknown
- 1998-06-01 MX MX9804343A patent/MX9804343A/en unknown

Also Published As

Publication number	Publication date
HUP9901935A2 (en)	1999-11-29
BR9611671A (en)	1999-12-28
JP2000513707A (en)	2000-10-17
NO982441L (en)	1998-05-28
WO1997020564A1 (en)	1997-06-12
MX9804343A (en)	1998-09-30
PL326970A1 (en)	1998-11-09
AU727001B2 (en)	2000-11-30
IL124647A0 (en)	1998-12-06
EP0869798A1 (en)	1998-10-14
AU7687896A (en)	1997-06-27
KR19990071628A (en)	1999-09-27
NO982441D0 (en)	1998-05-28

Similar Documents

Publication	Publication Date	Title
EP0745401A3 (en)	1997-06-11	Inhaler type medicine administering device
NZ508526A (en)	2004-12-24	Opioid formulations for treating pain
EP0692975A4 (en)	2000-11-29	Administration of vaso-active agent and therapeutic agent
PL312064A1 (en)	1996-07-08	Soft gelatinous form of pharmaceutical dose
EP0759306A3 (en)	1997-05-28	Medicine administering apparatus
GB2303064B (en)	1999-10-06	Medicament for nasal administration
WO1994027589A3 (en)	1995-01-26	Antidepressant dosage form
PL326149A1 (en)	1998-08-31	Pharmaceutic dipeptides containing angiostatic agents and methods of their application
EP0817655A4 (en)	1999-10-06	Intrapulmonary delivery of hematopoietic drug
AU9018898A (en)	1999-03-08	Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
BR9610983A (en)	1999-03-02	Stable forms of pharmaceutical administration containing parathormone
LT96148A (en)	1997-12-29	Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
ZA96576B (en)	1996-08-14	Extended-release solid oral dosage forms of drugs having low solubility in water
HUP9900186A3 (en)	2001-08-28	Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them
HUP9900147A2 (en)	1999-05-28	Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases
IL125913A0 (en)	1999-04-11	Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases
CA2120062A1 (en)	1994-11-11	Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
IL119459A0 (en)	1997-01-10	Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
HUP9901935A3 (en)	2001-04-28	Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
ZA9610039B (en)	1997-06-20	Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
ZA95908B (en)	1995-10-13	A synergistic formulation for treatment of rheumatic diseases
GB9524942D0 (en)	1996-02-07	Drug therapy
IL135171A0 (en)	2001-05-20	Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
GB9401745D0 (en)	1994-03-23	Improvements in and relating to the administration of medicaments or therapeutic substances
GB9503322D0 (en)	1995-04-12	Medicament administration dummy

Legal Events

Date	Code	Title	Description
2012-09-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished